These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 28888363)

  • 1. Effect of complete or partial proteinuria recovery on long-term outcomes of lupus nephritis.
    Medina-Rosas J; Fung WA; Su J; Touma Z
    Semin Arthritis Rheum; 2018 Feb; 47(4):557-564. PubMed ID: 28888363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of stringent response in proteinuria on long-term renal outcomes in proliferative lupus nephritis.
    Won J; Lee JS; Oh JS; Kim YG; Lee CK; Yoo B; Hong S
    Lupus; 2019 Oct; 28(11):1294-1301. PubMed ID: 31583978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal Remission Status and Longterm Renal Survival in Patients with Lupus Nephritis: A Retrospective Cohort Analysis.
    Davidson JE; Fu Q; Ji B; Rao S; Roth D; Magder LS; Petri M
    J Rheumatol; 2018 May; 45(5):671-677. PubMed ID: 29496892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to therapy at 6 months predicts long-term renal outcome in lupus nephritis with poor kidney function.
    Luo H; Zhou Y; Chen G; Ren Q; Zhao J; Ye W; Qin Y; Li X
    Lupus Sci Med; 2022 Dec; 9(1):. PubMed ID: 36581380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presentation and outcome of pediatric lupus nephritis from a large single centre contemporary cohort in Eastern India.
    Biswas D; Dasgupta D; Pal P; Sinha R
    Lupus; 2023 Oct; 32(12):1440-1446. PubMed ID: 37707867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of partial renal response by 12 weeks after induction therapy predicts poor renal response and systemic damage accrual in lupus nephritis class III or IV.
    Hanaoka H; Yamada H; Kiyokawa T; Iida H; Suzuki T; Yamasaki Y; Ooka S; Nagafuchi H; Okazaki T; Ichikawa D; Shirai S; Shibagaki Y; Koike J; Ozaki S
    Arthritis Res Ther; 2017 Jan; 19(1):4. PubMed ID: 28086993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time to recovery from proteinuria in patients with lupus nephritis receiving standard treatment.
    Touma Z; Urowitz MB; Ibañez D; Gladman DD
    J Rheumatol; 2014 Apr; 41(4):688-97. PubMed ID: 24429170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors predictive of long-term mortality in lupus nephritis: a multicenter retrospective study of a Japanese cohort.
    Ichinose K; Kitamura M; Sato S; Fujikawa K; Horai Y; Matsuoka N; Tsuboi M; Nonaka F; Shimizu T; Fukui S; Umeda M; Koga T; Kawashiri S; Iwamoto N; Tamai M; Nakamura H; Origuchi T; Nishino T; Kawakami A
    Lupus; 2019 Mar; 28(3):295-303. PubMed ID: 30700214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination immunosuppressant therapy and lupus nephritis outcome: a hospital-based study.
    Chen YM; Hung WT; Liao YW; Hsu CY; Hsieh TY; Chen HH; Hsieh CW; Lin CT; Lai KL; Tang KT; Tseng CW; Huang WN; Chen YH
    Lupus; 2019 Apr; 28(5):658-666. PubMed ID: 30971165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of associated factors for remission and relapse in proliferative and membranous lupus nephritis patients: a 4-year follow-up study].
    Qi CJ; Ye BX; Ni ZH; Cao LO; Zhang MF; Mou S; Wang Q; Yan YC; Fang W; Zhu ML; Lu RH; Qian JQ
    Zhonghua Yi Xue Za Zhi; 2013 Dec; 93(48):3826-30. PubMed ID: 24548442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of Good Long-Term Renal Outcomes in Lupus Nephritis: Results from a Single Lupus Cohort.
    Fung WA; Su J; Touma Z
    Biomed Res Int; 2017; 2017():5312960. PubMed ID: 28904963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remission of proteinuria indicates good prognosis in patients with diffuse proliferative lupus nephritis.
    Koo HS; Kim S; Chin HJ
    Lupus; 2016 Jan; 25(1):3-11. PubMed ID: 26159540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glomerulomegaly in lupus nephritis: a prognostic marker for renal outcomes.
    Hanaoka H; Kuwana M; Takeuchi T
    Int J Rheum Dis; 2015 Sep; 18(7):768-75. PubMed ID: 26179413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Lupus Nephritis Induction Treatments in a Hispanic Population: A Single-center Cohort Analysis.
    Mejía-Vilet JM; Arreola-Guerra JM; Córdova-Sánchez BM; Morales-Buenrostro LE; Uribe-Uribe NO; Correa-Rotter R
    J Rheumatol; 2015 Nov; 42(11):2082-91. PubMed ID: 26373566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained complete renal remission is a predictor of reduced mortality, chronic kidney disease and end-stage renal disease in lupus nephritis.
    Pakchotanon R; Gladman DD; Su J; Urowitz MB
    Lupus; 2018 Mar; 27(3):468-474. PubMed ID: 28857717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids.
    Condon MB; Ashby D; Pepper RJ; Cook HT; Levy JB; Griffith M; Cairns TD; Lightstone L
    Ann Rheum Dis; 2013 Aug; 72(8):1280-6. PubMed ID: 23740227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological findings, treatment response and predictors of long-term outcome in a cohort of lupus nephritis patients managed according to the Euro-lupus regime: a retrospective analysis in Sri Lanka.
    Herath N; Ratnatunga N; Weerakoon K; Wazil A; Nanayakkara N
    BMC Res Notes; 2017 Feb; 10(1):80. PubMed ID: 28148285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term data on tacrolimus treatment in lupus nephritis.
    Yap DY; Ma MK; Mok MM; Kwan LP; Chan GC; Chan TM
    Rheumatology (Oxford); 2014 Dec; 53(12):2232-7. PubMed ID: 24996908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronicity index, especially glomerular sclerosis, is the most powerful predictor of renal response following immunosuppressive treatment in patients with lupus nephritis.
    Park DJ; Choi SE; Xu H; Kang JH; Lee KE; Lee JS; Choi YD; Lee SS
    Int J Rheum Dis; 2018 Feb; 21(2):458-467. PubMed ID: 29314776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycophenolate as induction therapy in lupus nephritis with renal function impairment.
    Rivera F; Fulladosa X; Poveda R; Frutos MA; García-Frías P; Ara J; Illescas L; López-Rubio E; Mérida E; Carreño A; Ballarín J; Fernández-Juárez G; Baltar J; Ramos C; Pons S; Oliet A; Vigil A; Praga M; Segarra A;
    Am J Nephrol; 2012; 35(5):424-33. PubMed ID: 22517244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.